NCT04641572 is a NA clinical trial of Choose comfortable position in Childbirth Process, sponsored by Woman's Health University Hospital, Egypt.

Who is sponsoring NCT04641572?

NCT04641572 is sponsored by Woman's Health University Hospital, Egypt.

What drugs are being tested in NCT04641572?

Interventions in NCT04641572: Choose comfortable position.

What condition does NCT04641572 study?

NCT04641572 studies Childbirth Process.

Is NCT04641572 still recruiting?

NCT04641572 is currently status unknown. Last updated 24 November 2020.

Last reviewed 2020-11-24 · How we verify

NCT04641572

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Different Positions During Childbirth

Status unknown NA Last updated 24 November 2020

What this trial tests

NA trial testing Choose comfortable position in Childbirth Process in 300 participants. Status unknown.

Timeline

1 June 2020

Primary endpoint
30 December 2020

30 December 2020

Quick facts

Lead sponsor	Woman's Health University Hospital, Egypt
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	supportive care
Enrollment	300
Start date	1 June 2020
Primary completion	30 December 2020
Estimated completion	30 December 2020
Sites	1 location across Egypt

Drugs / interventions tested

Choose comfortable position

Conditions studied

Childbirth Process — all drugs for Childbirth Process →

Sponsor

Woman's Health University Hospital, Egypt

Who can join

Adults 18 to 45, female only, with Childbirth Process. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To encourage the application the recommended positions of the World Health Organization during normal childbirth and its effect on maternal and labor outcomes

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Woman's Health University Hospital, Egypt trials

Trials by the same sponsor.

NCT05771922 — Implication of New High Resolution Ultrasonographic Modalities for Diagnosis of Fetal Nervous System Anomalies · recruiting
NCT05778279 — Role of New High Resolution Ultrasonographic Modalities for Diagnosis of Fetal Nervous System Anomalies · recruiting
NCT05734287 — The Frequency of Polycystic Ovary Syndrome Among Young Reproductive Females Presenting With Hyperandrogenism: a Mixed Co · recruiting
NCT04357054 — Darwish Hysteroscopic Test (Hysteroscopic Bubble Suction and Tubal Peristalsis of Darwish Triad) in Myomatous Uterus · NA · unknown
NCT04825041 — Efficacy of Hysteroscopic Bubble Test, Flow Test and Peristalsis Test. · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04641572 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Woman's Health University Hospital, Egypt
Last refreshed: 24 November 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04641572.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing